Literature DB >> 11918896

Identification of progressive glaucomatous visual field loss.

Paul G D Spry1, Chris A Johnson.   

Abstract

In normal individuals, visual field measures are not perfectly repeatable and individual test locations exhibit both short- and long-term sensitivity variations. This physiologic variability is greatly increased in glaucoma and confounds detection of real progressive loss in visual function. Distinguishing progressive glaucomatous visual field loss from test variability therefore represents a complex task. Procedures used for detection of glaucomatous visual field progression may be broadly grouped into four categories: 1) clinical judgment, which consists of simple subjective observation of sequential visual field test results; 2) defect classification systems, whereby specific criteria are used to stratify field loss by discrete score and define progression as score change over time, such as the Advanced Glaucoma Intervention Study scoring system; 3) trend analyses, which follow test parameters sequentially over time to determine the magnitude and significance of patterns within the data, for example linear regression; and 4) event analyses, which identify single events of significant change relative to a reference examination. All of these methods demonstrate distinct benefits and drawbacks, making each useful in specific circumstances, although no single method appears universally ideal. At the present time the best method of detection of progression may be to rely upon confirmation of change at successive examinations and also by correlation of visual field changes with other clinical observations. Alternative analysis methods may become available in the near future to help identify cases of progressive loss.

Entities:  

Mesh:

Year:  2002        PMID: 11918896     DOI: 10.1016/s0039-6257(01)00299-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  37 in total

1.  Measurement error of visual field tests in glaucoma.

Authors:  P G D Spry; C A Johnson; A M McKendrick; A Turpin
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Normal visual field test results following glaucomatous visual field end points in the Ocular Hypertension Treatment Study.

Authors:  John L Keltner; Chris A Johnson; Richard A Levine; Juanjuan Fan; Kimberly E Cello; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2005-09

3.  Bayes' theorem applied to perimetric progression detection in glaucoma: from specificity to positive predictive value.

Authors:  Nomdo M Jansonius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-01       Impact factor: 3.117

4.  Towards an optimal perimetric strategy for progression detection in glaucoma: from fixed-space to adaptive inter-test intervals.

Authors:  Nomdo M Jansonius
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-28       Impact factor: 3.117

Review 5.  Ageing and visual field data.

Authors:  Paolo Brusini
Journal:  Br J Ophthalmol       Date:  2007-10       Impact factor: 4.638

6.  Evaluation of Visual Field and Imaging Outcomes for Glaucoma Clinical Trials (An American Ophthalomological Society Thesis).

Authors:  David F Garway-Heath; Ana Quartilho; Philip Prah; David P Crabb; Qian Cheng; Haogang Zhu
Journal:  Trans Am Ophthalmol Soc       Date:  2017-08-22

7.  Predicting Clinical Binary Outcome Using Multivariate Longitudinal Data: Application to Patients with Newly Diagnosed Primary Open-Angle Glaucoma.

Authors:  Feng Gao; J Philip Miller; Julia A Beiser; Chengjie Xiong; Mae O Gordon
Journal:  J Biom Biostat       Date:  2015-10-26

8.  Is there evidence for continued learning over multiple years in perimetry?

Authors:  Stuart K Gardiner; Shaban Demirel; Chris A Johnson
Journal:  Optom Vis Sci       Date:  2008-11       Impact factor: 1.973

9.  Performance of glaucoma progression analysis software in a glaucoma population.

Authors:  Francisco Arnalich-Montiel; Pilar Casas-Llera; Francisco J Muñoz-Negrete; Gema Rebolleda
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-04       Impact factor: 3.117

10.  Specification of progression in glaucomatous visual field loss, applying locally condensed stimulus arrangements.

Authors:  Jukka Nevalainen; Jens Paetzold; Eleni Papageorgiou; Pamela A Sample; John P Pascual; Elke Krapp; Bettina Selig; Reinhard Vonthein; Ulrich Schiefer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.